SGMO
Sangamo Therapeutics Inc.
Company Overview
| Mkt Cap | $178.16M | Price | $0.60 |
| Volume | 4.49M | Change | +4.55% |
| P/E Ratio | -1.8 | Open | $0.58 |
| Revenue | $57.8M | Prev Close | $0.57 |
| Net Income | $-97.9M | 52W Range | $0.41 - $3.18 |
| Div Yield | N/A | Target | $4.10 |
| Overall | 38 | Value | 40 |
| Quality | 39 | Technical | 36 |
No chart data available
Stock Overview
Updated DailySangamo Therapeutics Inc. (SGMO) is a leading Healthcare company in the Biotechnology industry, currently trading at $0.60 with a market capitalization of $178.16 million. The stock is approaching its 52-week lows, suggesting potential value opportunity, demonstrating concerning quality fundamentals with a MarketXLS quality score of 39.
Today's trading session shows SGMO with a volume of 4.49 million shares. The stock opened up 1.50% from yesterday's close of $0.57. Current analyst estimates project earnings of $-0.28 per share for this year, with next year targeting $-0.28.
SGMO demonstrates concerning technical signals based on technical analysis. The company trades on the NSC exchange and operates alongside industry peers including ALNY, GILD, AMGN, BIIB, BMRN.
Key investment considerations for SGMO include concerning overall investment profile. The company offers a dividend yield of NA% and analyst price targets suggest potential upside of 585.6%. The stock shows elevated valuation levels based on valuation analysis.
Analysis generated on November 3, 2025 at 07:28 AM
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | SGMO | $0.60 | +4.5% | 4.49M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Sangamo Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW